Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Panacea Venture is a life sciences venture fund established in 2017, emerging from Kleiner Perkins China. The firm operates from multiple locations, including Shanghai, Boston, and Silicon Valley, positioning itself strategically to tap into global healthcare markets. With a focus on early-stage and growth-stage investments, Panacea Venture has built a diverse portfolio that includes over 30 companies, both private and public.
The firm emphasizes its commitment to addressing unmet medical needs through innovative healthcare solutions. Notable milestones include its rapid growth since inception and its ability to attract significant investments in the life sciences sector. Panacea Venture's geographic focus spans across Asia, particularly China, where it leverages local expertise to identify promising startups.
Panacea Venture invests in early-stage companies that develop breakthrough technologies aimed at solving unmet medical needs. The firm’s investment strategy encompasses a wide range of sectors, including therapeutics, small molecules, biologics, alternative modalities, cell and gene therapy, and R&D services. This broad focus allows Panacea to engage with various innovative healthcare solutions.
Investment stages range from pre-seed to growth equity, enabling the firm to support companies at different points in their development. The firm particularly emphasizes its expertise in the Asian market, especially in China, where it seeks to capitalize on emerging trends in life sciences. Panacea Venture looks for founders who demonstrate a strong vision and capability to execute their innovative ideas.
Panacea Venture's portfolio includes over 30 companies, showcasing a commitment to innovative healthcare solutions. Notable investments include:
This diverse portfolio reflects Panacea Venture's strategic focus on addressing critical healthcare challenges through innovative technologies.
James Huang: Founder and Managing Partner, previously associated with Kleiner Perkins, brings extensive experience in venture capital and life sciences.
Andrew Aherrera: Partner with a background in healthcare investments, focusing on innovative biotech solutions.
Cheryl Bao: Chief Legal Officer, responsible for overseeing legal matters and compliance within the firm.
Benjamin Chen: Scientific Partner, with expertise in drug development and biotechnology.
Arthur Chen: Partner, specializing in early-stage investments in the life sciences sector.
Michelle Chung: Venture Partner, contributing insights into market trends and investment opportunities.
Delia Ding: Chief Financial Officer, managing the financial operations and strategy of the firm.
Nancy Donahue: Venture Partner, focusing on strategic partnerships and portfolio management.
Carl Firth: Partner, with a strong background in healthcare and technology investments.
To pitch Panacea Venture, founders should send their proposals via email to info@panaceaventure.com. A concise pitch deck is essential, highlighting the technology, market opportunity, and team qualifications. Founders should expect a response within a few weeks, and warm introductions are preferred but not mandatory.
In recent months, Panacea Venture has continued to expand its portfolio, actively investing in innovative healthcare solutions. The firm remains focused on supporting early-stage and growth-stage companies, particularly in the biotech sector. Specific investment announcements and portfolio updates have not been detailed, but the firm maintains a strong presence in the life sciences investment community.
What investment criteria does Panacea Venture prioritize?
Panacea Venture focuses on early-stage companies with breakthrough technologies that address unmet medical needs. They prioritize sectors such as therapeutics, biologics, and cell therapy.
How can founders pitch to Panacea Venture?
Founders can reach out via email at info@panaceaventure.com. A well-prepared pitch deck that outlines the technology, market potential, and team is essential.
What makes Panacea Venture different from other investors?
Panacea Venture specializes in life sciences and has a strong emphasis on the Asian market, particularly China. Their deep expertise in healthcare innovation sets them apart.
What is the geographic scope of Panacea Venture's investments?
The firm has a global investment strategy with a specific focus on Asia, leveraging local insights to identify promising healthcare startups.
What is the typical check size for investments?
While specific check sizes are not disclosed, Panacea Venture invests across various stages, from pre-seed to growth equity, indicating flexibility in funding amounts.
What kind of post-investment involvement does Panacea Venture have?
Panacea Venture actively supports its portfolio companies through mentorship, operational guidance, and access to its extensive network in the life sciences sector.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.